Scientists at BIDMC in collaboration with @themmrf.bsky.social and leading institutions across the country, have contributed to one of the largest efforts to date to map the cellular microenvironment of #multiplemyeloma tumors. 📝 @natcancer.nature.com Learn more➡️ bit.ly/49gHNbo #MMSM #Oncology

Save the Date: BIDMC Liver Tumor Symposium - Highlighting advances in liver transplant, risk stratification & surveillance, therapeutic strategies, and more. 🗓️Thursday, 3/5/26 ⌚️5 - 9 PM 📍Sheraton Boston Needham Hotel #HCC #LiverCancer #OncSky #Oncology #CancerResearch

📢 Live from our first Cancer Research Institute seminar of 2026: Andy Chan, MD, MPH, Mass Gen Brigham Cancer Institute addresses molecular prevention of #colorectalcancer ( #CRC). An epidemiologist, he highlights the role of Aspirin in CRC incidence, prevention, and more. #CancerResearch #OncSky

Gliomas are diffuse in nature, making tumor margins difficult to see with the naked eye, says Rafael Vega, MD, PhD, Director, Brain Tumor Center, BIDMC. Modern surgical techniques and advanced brain imaging help neurosurgeons remove gliomas more effectively. #NeuroOncology #OncSky ➡️ bit.ly/3NkAJ4V

🔬 #CancerResearch Spotlight: AKT activation mitigates efficacy of androgen receptor (AR) targeted therapy in TMPRSS2:ERG fusion #ProstateCancer. 💡Patients with T:E fusion prostate cancer may benefit from combination therapy targeting AR and AKT. 📝Steven Balk MD, PhD, BIDMC @the-asci.org

As #ASH25 comes to a close, we are grateful for the opportunity to connect with colleagues near and far on groundbreaking research in hematology & blood cancers, and advances in patient care! #Hematology #Oncology #Fight4Hematology

#ASH25 Highlights: “Effects of Duffy Status on Patients with #BreastCancer Receiving CDK 4/6 Inhibitors - Grace Ferri, MD, BIDMC + collaborators from Boston Medical Center #Hematology #Oncology

#ASH25 highlight: A multidisciplinary look at thrombosis risk in #MultipleMyeloma patients treated with carfilzomib-based regimens - a systematic review and meta-analysis of clinical trials @rushadpatell.bsky.social #MMsm #Hematology

📸 The BIDMC Hematology & Hematologic Malignancies team dinner #ASH25 #HemSky Grateful for the amazing setting and opportunity to connect with colleagues!

Join us today, 12/3, at 4 PM for our Cancer Research Institute seminar series, featuring Kipp Weiskopf, MD, PhD. He leads a research lab that studies macrophages and other innate immune cells in the tumor microenvironment. Dr. Weiskopf is also an inventor on 20+ issued U.S. patents. #CancerResearch

🎉Our friends at Winchester Hospital hosted their annual “Celebrate Life” cancer survivor’s event. This get-together of clinicians and patients honors those who have survived cancer and inspires newly diagnosed patients and their families. ➡️More: bit.ly/44tNrUA #OncSky

New analysis in @jama.com : - Only 1 in 5 eligible Americans were screened for #lungcancer in 2024 - If screening increased to 100%, 62k deaths over 5 years could be prevented @maraschonberg.bsky.social, BIDMC Dept. of Medicine, shares comments @nytimes.com ⏩ nyti.ms/4im3uK0 #LungCancerAwareness

📸 Frank Slack, PhD, BIDMC Cancer Research Institute Director, and his lab at our 2025 #CancerSymposium Thank you to all who joined us on Friday for our 18th annual Cancer Symposium! It was a day rich with cutting edge #cancerresearch and invigorating discussion.

Live from our #CancerSymposium - our debut poster session, featuring groundbreaking science in topics like cancer metabolism & biology, novel therapeutic targets, epigenetics & gene regulation, and more. #CancerResearch

Live from our #CancerSymposium - Dr. Kiame Mahaniah, Health and Human Services Secretary, Massachusetts, at our opening remarks, “Reducing the burden of #cancer in Massachusetts is a shared responsibility.” #CancerResearch

#CancerSymposium speaker spotlight: Robert Soiffer, MD, @danafarber.bsky.social - his research focuses on modulation of immune responses in hematopoietic stem cell transplantation. Join us THIS Friday, 11/21 at the Joseph B. Martin Conference Center. Register➡️ bit.ly/46IdysL

📢 We are 3 days away from our #CancerSymposium! Join us for a day of invigorating discussion with leading oncology experts, a poster session, and networking opportunities. 🗓️ Friday, 11/21 📍 Joseph B. Martin Conference Center ⌚️ 9 AM - 5 PM Register now ➡️ bit.ly/46IdysL

#CancerSymposium speaker spotlight: Renier Brentjens, MD, PhD @roswellpark.bsky.social - his ongoing research is focused on “armored CAR T cells” and their translation into the clinical setting. Join us THIS Friday, 11/21 at the Joseph B. Martin Conference Center. Register now ➡️ bit.ly/46IdysL

#CancerSymposium speaker: Andrew Aguirre, MD, PhD @danafarber.bsky.social @harvardmed.bsky.social @broadinstitute.org - He leads a basic and translational research lab that studies #pancreaticcancer biology and RAS signaling to develop new therapeutic strategies for patients. ➡️ bit.ly/46IdysL

We are one week away from our #CancerSymposium! This year's program includes keynote presentations, a poster session, a panel discussion highlighting the future of cancer care, and more. 🗓️Friday, 11/21 📍Joseph B. Martin Conference Center ⌚️9 AM - 5 PM ➡️ bit.ly/46IdysL #CancerResearch #OncSky

Alice Shaw, MD, PhD @danafarber.bsky.social studies resistance to targeted therapies and helps develop targeted therapies for patients with oncogene-driven #lungcancer. Hear from Dr. Shaw at our #CancerSymposium next week on Friday, 11/21. Register now➡️ bit.ly/46IdysL

⭐️ #CancerSymposium speaker spotlight: David E. Fisher, MD, PhD, MGH. His research focuses on the molecular and genetic drivers of #melanoma, translating discoveries into advances in skin cancer care. Join us Friday, 11/21 from 9 AM - 5 PM at the Joseph B. Martin Conference Center. ➡️ bit.ly/46IdysL

Recap from our #CancerResearch seminar series, Kivanç Birsoy, PhD @rockefeller.edu spoke about understanding the role of compartmentalized metabolism in physiology and cancer. Thanks to everyone who came, there wasn’t a free seat left - a lot of interest in this topic! Moderator: @ptrt.bsky.social

Join us tomorrow, 11/5 at 4 PM for our #CancerResearch seminar feat. Dr. Kıvanç Birsoy @rockefeller.edu. His lab studies how metabolic pathways influence cellular function and diseases like cancer, uncovering how cells adapt nutrient use to reveal new potential therapeutic targets.

What's holding you back from getting screened? We encourage patients and their families to attend one of our #cervicalcancer screening events this month (English & Spanish). Walk away feeling confident and informed in your health decisions. ➡️Learn more: bit.ly/47OaEmy

We are less than one month away from our 18th annual #CancerSymposium! This one-day event features keynote speakers, an expert panel discussion, a poster session, and more. Join us! 🗓️11/21, Joseph B. Martin Conference Center ⌚️9 AM - 5 PM ➡️Register: bit.ly/46IdysL #CancerResearch #OncSky #CanSky

💡 #CancerResearch Spotlight: @davidjeinstein.bsky.social BIDMC #MedOnc et al @jco-asco.bsky.social address NCI clinical trial considerations for #BCR #prostatecancer. Key findings: - New term, "(PSMA)+BCR" - High-risk BCR with PSA doubling time of ≤6 months - Balance treatment with patient QoL

⭐️This honor from Becker's Healthcare reflects our commitment to advancing cancer care through groundbreaking research, innovative therapies & compassionate, patient-centered care. We continue to push the boundaries of what’s possible in cancer treatment & research. ➡️ bit.ly/49e3xVB #Oncology #OncSky

💡Live from our Cancer Research Institute seminar series - @srviswanathan.bsky.social @danafarber.bsky.social presents “From X-Chromosome Genetics to Cancer Dependencies: Insights from the Study of a Rare #KidneyCancer (tRcc)”. Great turnout today - thanks to all who joined! #CancerResearch #Oncology

💛Team BIDMC Hem/Onc raised their lanterns at Blood Cancer United’s Light the Night to honor patients and loved ones impacted by blood cancers. We raised $1,820 to support lifesaving research, treatments, and support services for patients with blood cancer.

Our #CancerSymposium is full of networking opportunities, whether it's speakers sharing ideas at the roundtable, research colleagues chatting over coffee, or friends catching up at cocktail hour. 🗓️11/21, Joseph B. Martin Conference Center ⌚️9 AM - 5 PM ➡️Register: bit.ly/46IdysL

🩸BIDMC is a proud route sponsor of this year's Blood Cancer United Light the Night in Boston. Our extraordinary hematologic nurses have also started a fundraising team. Together, we will help bring light to the darkness of cancer. ➡️Learn more about our team: bit.ly/48ZeMRF

📸That's a wrap #ASCOQLTY25! We're grateful to have shared numerous studies which demonstrate our commitment to quality & safety in cancer care delivery. ⭐️Highlights: tumor board redesign, multidisciplinary oncology clinics, community-based cancer screening, and our nurse navigation program.

Excited to share our findings regarding #financialtoxicity of our patients with prostate cancer presenting for #radiationtherapy @bidmc-cancercenter.bsky.social @bidmcreseach.bsky.social ! And excited to learn more about delivery of quality care and barriers to cancer care at #ASCOQLTY25!

🌟 Frank Slack, PhD, HMS/BIDMC and Gary Ruvkun, PhD showing off their formal wear at the #NobelPrize Banquet in Stolkholm - a beautiful night to celebrate the discovery of microRNA and its role in post-transcriptional gene regulation 🧬 Congrats to Dr. Ruvkun & Dr. Ambros for their achievements!

Please join us for our Cancer Research Institute Seminar Series this Thursday, 12/12 at 4 PM, featuring @vanallenlab.bsky.social. His lab specializes in cancer genomics and precision medicine, and has made significant advances in understanding the molecular origins of cancer #CancerResearch

🏆Director of the Harvard Med School Initiative for RNA Medicine & BIDMC Cancer Research Institute Director Frank Slack, PhD was honored at the 2024 Nobel Prize Award Ceremony for supporting Gary Ruvkun in the discovery of microRNA and its role in gene regulation. An outstanding achievement!

Our Malignant and Benign Hematology team is in full force at #ASH24! It’s been an outstanding event rich with great conversations and a lot of fun. There’s a lot of gratitude to share for this outstanding group of clinicians, fellows, researchers and friends #Hemesky #hematology

Live from our Cancer Research Institute Seminar Series: Sohail Tavazoie, MD, PhD, @rockefelleruniv.bsky.social presents groundbreaking findings on how genetics and the nervous system impact cancer metastasis. Key findings on ApoE in #melanoma, DRG neurons in #breastcancer, & more. #CancerResearch

Last week, Beth Israel Lahey Health hosted its #BreastCancer Symposium. Our BreastCare Center clinical team joined breast oncology leaders from across BILH to discuss advancing patient-centered care. Highlights included a patient speaker, case panel, and more! #BCSM #MedSky #OncSky

📢 Live from our Cancer Research Institute Seminar Series - Mikala Egeblad, PhD @hopkinsmedicine.bsky.social presents her lab’s research on the tumor microenvironment, and the interplay between cancer cells and myeloid-derived immune cells, like neutrophils #CancerResearch

Excited to join the growing medical and scientific communities on BlueSky 😄 We are a robust team of scientists and clinicians that are revolutionizing the future of #cancerresearch and #cancer care. What are you interested in hearing from us? Let's connect! #OncSky #MedOnc #HemeOnc #hemeSky #MedSky